Case study:

There is a huge pharmaceutical industry in India. Their govt. is giving many

opportunities for Indian companies. Because they need to compete with

multinational company. Although they have to many rules and regulation

maintain their market situation. They also export their products to abroad.

There are also great market for their medicine. Their also earning large

amount of money from this industry. There are some barriers also. For

exporting they have to follow several steps. As they have to maintain the

quality of those pharmaceutical products.

Biocon India Group:

Biocon india is enzyme manufacture. They started their business 1978. Their

products are necessary in beer industry. Basically they follow Japanese

fermentation process. Because they industry was dominated by one

Japanese company.

Syngene:

This is contract research organization. This is a subsidiary organization of

Biocon. It increases Biocon business area. They have expended a lot in their

business. And Indian CRO condition is also emerging. So they are facing a

great opportunity.

Biocon India to expand:

Biocon group is highly related to pharmaceutical industry. They have a lot of

opportunity in

Because some factors effects Biocon business.

Government favor:

In India, many company involved in pharmaceutical industry. Although they

are restricted by many rules. But India govt. helps them by giving several

opportunities.

Outsourcing:

There are basic customers of biocon who are from abroad. They have a huge

business area to invest. They can money from foreign industry. America is

their one of the best consumer.

Several industrys experience:

Biocon started their business from fermentation. After that they became an

enzyme provider. Then they made an organization which is contract research

organization. Which is related to outsourcing.

Opportunity of Biocon:

Biocon wants to start a pharmaceutical research center. This basically huge

opportunity biocon for entering a new industry. Although there is some risks,

but opportunities are higher than their risks. This would be an innovation for
their pharmaceutical industry. Biocon is one of the leading company for

enzyme industry. As they started their business from fermentation, so they

are already involved with following industry. And research center help

researcher to research on pharmaceutical product. There would be many

students. This is also a profitable factor. I suggest Biocon to invest in

pharmaceutical industry.